With a focus on alleviating human suffering (pain) and rescuing society from the on-going opioid crisis, CerSci Therapeutics is poised to deliver a new generation of non-opioid medicines to treat acute post-operative and chronic neuropathic pain (including diabetic- and chemotherapy-induced).
Check out CerSci in the press right here!
The mission of CerSci Therapeutics is singular- pain relief from new drugs developed from understanding mechanisms which cause pain, and conquering resultant neuronal sensitization. This mandate sets CerSci apart from other companies with analgesic products / programs. Our research is supported by robust scientific data and backed by a team with synergistic expertise. Our first drug will go into human clinical trials in 2018, we expect to receive FDA high-priority status and we will provide an efficacy readout in late 2018.
Copyright © CERSCI Therapeutics. All Rights Reserved